Cheryl Cho-Phan

Medical oncologist, GI specialist

Clinical Assistant Professor, Medicine - Oncology

Gastrointestinal (GI) Cancer Program

  • 875 Blake Wilbur Drive
  • Palo Alto, CA 94304
  • Phone: 650-498-6000
Learn More About the Clinic Getting Here Make An Appointment

Professional Education

Internship: Oregon Health Sciences Univ Hospital (1997) OR

Residency: Oregon Health Sciences Univ Hospital (1999) OR

Fellowship: Stanford University School of Medicine (2002) CA

Medical Education: Georgetown University Hospital (1996) DC

Increased Long-term Survival Among Patients With Hepatocellular Carcinoma After Implementation of Model for End-stage Liver Disease Score.
Wong, R. J., Devaki, P., Nguyen, L., Cheung, R., Cho-Phan, C., & Nguyen, M. H. (2014). Increased Long-term Survival Among Patients With Hepatocellular Carcinoma After Implementation of Model for End-stage Liver Disease Score. Clinical gastroenterology and hepatology , 12(9), 1534-1540 e1.

Increased Long-term Survival Among Patients With Hepatocellular Carcinoma After Implementation of Model for End-stage Liver Disease Score
Wong, R. J., Devaki, P., Long Nguyen, L., Cheung, R., Cho-Phan, C., & Nguyen, M. H. (2014). Increased Long-term Survival Among Patients With Hepatocellular Carcinoma After Implementation of Model for End-stage Liver Disease Score. CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 12(9), 1534-U323.

Limitations of Body Surface Area-Based Activity Calculation for Radioembolization of Hepatic Metastases in Colorectal Cancer
Lam, M. Geh., Louie, J. D., Abdelmaksoud, M. Hk., Fisher, G. A., Cho-Phan, C. D., & Sze, D. Y. (2014). Limitations of Body Surface Area-Based Activity Calculation for Radioembolization of Hepatic Metastases in Colorectal Cancer. JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY, 25(7), 1085-1093.

A Phase II Study of Gefitinib, 5-Fluorouracil, Leucovorin, and Oxaliplatin in Previously Untreated Patients with Metastatic Colorectal Cancer
Fischer, Ga., Kuo, T., Ramsey, M., Schwartz, E., Rouse, Rv., & Sikic, B. I. (2008). A Phase II Study of Gefitinib, 5-Fluorouracil, Leucovorin, and Oxaliplatin in Previously Untreated Patients with Metastatic Colorectal Cancer. CLINICAL CANCER RESEARCH, 14(21), 7074-7079.

Phase I study of stereotactic radiosurgery in patients with locally advanced pancreatic cancer
Koong, A. C., Le, Q. T., Ho, A., Fong, B., Fisher, G., & Bastidas, J. A. (2004). Phase I study of stereotactic radiosurgery in patients with locally advanced pancreatic cancer. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 58(4), 1017-1021.

Phase I and pharmacokinetic study of BMS-188797, a new taxane analog, administered on a weekly schedule in patients with advanced malignancies
Advani, R., Fisher, G. A., Lum, B. L., Jambalos, C., Cho, C. D., & Sikic, B. I. (2003). Phase I and pharmacokinetic study of BMS-188797, a new taxane analog, administered on a weekly schedule in patients with advanced malignancies. CLINICAL CANCER RESEARCH, 9(14), 5187-5194.

Phase II trial of preoperative 3D conformal radiotherapy, protracted venous infusion 5-fluorouracil, and weekly CPT-11, followed by surgery for ultrasound-staged T3 rectal cancer
Mehta, V. K., Cho, C., Ford, J. M., Jambalos, C., Poen, J., & Fisher, G. (2003). Phase II trial of preoperative 3D conformal radiotherapy, protracted venous infusion 5-fluorouracil, and weekly CPT-11, followed by surgery for ultrasound-staged T3 rectal cancer. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 55(1), 132-137.